EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT AND RANIBIZUMAB IN ASIAN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Subgroup Analyses From the VIEW Trials.

Retina · 2019 · PMC6410967 · PMID 29280937

Europe PMC DOI

hedged sentence

0.0075

closest p · 0.1× alpha

0.0075

boldest claim

The sentences

nominally significantP = 0.0075actually significant

The differences in decrease were nominally significant in favor of intravitreal aflibercept for 2q4 versus Rq4 and 2q8 versus Rq4 ( P = 0.0075 and P = 0.0126, respectively).

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.